Gemcitabine Exhibits a Suppressive Effect on Pancreatic Cancer Cell Growth by Regulating Processing of PVT1 to miR1207

Molecular Oncology - Netherlands
doi 10.1002/1878-0261.12393
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Enhanced Antitumor Efficacy of Gemcitabine by Evodiamine on Pancreatic Cancer via Regulating PI3K/Akt Pathway

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2012English

Gemcitabine Promotes Immune Escape of Pancreatic Cancer by Down Regulating the Soluble ULBP2 Protein

Oncotarget
Oncology
2016English

Apoptosis Signal-Regulating Kinase 1 Exhibits Oncogenic Activity in Pancreatic Cancer

Oncotarget
Oncology
2016English

Inhibitory Effect of Baicalein Combined With Gemcitabine in Human Pancreatic Cancer Cell Lines

Oncology Letters
Cancer ResearchOncology
2018English

TP53INP1 Decreases Pancreatic Cancer Cell Migration by Regulating SPARC Expression

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

Pim-3 Promotes Human Pancreatic Cancer Growth by Regulating Tumor Vasculogenesis

Oncology Reports
MedicineCancer ResearchOncology
2014English

Establishment and Characterization of the Gemcitabine‑resistant Human Pancreatic Cancer Cell Line SW1990/gemcitabine

Oncology Letters
Cancer ResearchOncology
2019English

PVT1- Derived miR-1207-5p Promotes Breast Cancer Cell Growth by Targeting STAT6

Cancer Science
Cancer ResearchMedicineOncology
2017English

Demethylzeylasteral (ZST93) Inhibits Cell Growth and Enhances Cell Chemosensitivity to Gemcitabine in Human Pancreatic Cancer Cells via Apoptotic and Autophagic Pathways

International Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy